On-going Trials


BRAINS is a pilot study initiated by ATU University, Auckland, New-Zealand. It will include 140 subjects who experienced a mild or moderate traumatic brain injury (TBI). This placebo-controlled study aims to demonstrate NeuroAiD safety and efficacy in post-TBI recovery. The Principal Investigator is Prof Valery Feigin.


NEURITES is a study initiated in April 2013 by the National University of Singapore to establish NeuroAiD safety and efficacy for vascular cognitive impairment. The Principal Investigator is Prof Christopher Chen.

Additional trials are planned in Cognitive Impairment, Stroke and Alzheimer Dementia